Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
Acta Dermato-Venereologica|May 28, 2026
A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermanyCeleste Boesjes, Marjolein de Bruin-Weller, Nicolaas P A Zuithoff, et al.
The Journal of Allergy and Clinical Immunology|December 26, 2022
Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitisAnne-Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge, et al.
Acta Dermato-Venereologica|September 14, 2020
Management of Ocular Manifestations of Atopic Dermatitis: A Consensus Meeting Using a Modified Delphi ProcessJacob P Thyssen, Steffen Heegaard, Lena Ivert, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 19, 2011
The norepinephrine transporter gene is a candidate gene for panic disorderH N Buttenschøn, A S Kristensen, H N Buch, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Predicting Psoriatic Arthritis in Psoriasis Patients - A Swiss Registry StudyMia-Louise Nielsen, Troels C Petersen, Lara Valeska Maul, et al.
Journal of Cardiovascular Electrophysiology|September 8, 2023
Myocardial scarring and recurrence of ventricular arrhythmia in patients surviving an out-of-hospital cardiac arrestAnna F Thomsen, Bo G Winkel, Leticia Camino Castrillo Golvano, et al.
Geophysical Research Letters|March 5, 2019
Comparing Electron Energetics and UV Brightness in Jupiter's Northern Polar Region During Juno Perijove 5R W Ebert, T K Greathouse, G Clark, et al.
The Journal of Investigative Dermatology|April 21, 2023
Reduced Skin Microbiome Diversity in Infancy Is Associated with Increased Risk of Atopic Dermatitis in High-Risk ChildrenAnne-Sofie Halling, Blaine Gabriel Fritz, Trine Gerner, et al.
JAMA Dermatology|July 17, 2024
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for DiscontinuationReineke Soegiharto, Mehran Alizadeh Aghdam, Jennifer Astrup Sørensen, et al.
Allergy|October 8, 2024
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE studyR Soegiharto, M Alizadeh Aghdam, J A Sørensen, et al.
Pageof 29